Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
8.29
+0.78 (10.39%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Aardvark Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22
Market Capitalization
177---
Enterprise Value
104---
Debt / Equity Ratio
0.010.010.020.02
Quick Ratio
14.9514.957.2327.07
Current Ratio
15.0515.057.5027.72
Return on Equity (ROE)
-50.70%-50.70%-57.47%-
Return on Assets (ROA)
-32.35%-32.35%-33.96%-
Return on Capital (ROIC)
-34.67%-34.67%-36.34%-
Buyback Yield / Dilution
-0.90%-0.89%-1.78%-
Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q